Johnson & Johnson will not make TB medicine, due to this the company will not be able to do this work
‘US-based pharmaceutical company ‘Johnson & Johnson’ has recently announced that it will not enforce the patent of ‘Sirturo’ in 134 low and middle income countries. ‘Sirturo’ manufactures TB medicine under the brand name Bedaquiline. This medicine is a multidrug which treats TB. The move comes after Glauber put pressure on the company not to pursue …